Le Lézard
Classified in: Health
Subjects: MAV, EXE, NTA, FVT

Notice to the Media - MP Robert-Falcon Ouellette to participate in event to applaud First Nation Foot Care Program


OTTAWA, Oct. 5, 2017 /CNW/ - On behalf of the Honourable Jane Philpott, Minister of Indigenous Services, and the Honourable Ginette Petitpas Taylor, Minister of Health, Robert-Falcon Ouellette, Member of Parliament for Winnipeg Centre, will participate in an event to applaud the newly created First Nation Basic Foot Care Program.

Date
October 6, 2017

Time
11:30 a.m. CDT

Location
Nanaandawewigamig
(First Nations Health and Social Secretariat of Manitoba)
17th floor boardroom
275 Portage Avenue
Winnipeg, Manitoba

 

SOURCE Health Canada


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: